Efficacy and Safety of Sublingual Fentanyl Tablets in Treatment of Breakthrough Pain in Cancer Patients.
PHASE3CompletedINTERVENTIONAL
Timeline
Start Date
December 31, 2005
Primary Completion Date
December 31, 2008
Study Completion Date
January 31, 2009
Conditions
PainCancer
Interventions
DRUG
EN3267
Trial Locations (1)
27103
Carolinas Pain Institute, Winston-Salem
All Listed Sponsors
lead
Kyowa Kirin Co., Ltd.
INDUSTRY
NCT00262678 - Efficacy and Safety of Sublingual Fentanyl Tablets in Treatment of Breakthrough Pain in Cancer Patients. | Biotech Hunter | Biotech Hunter